Seven Eight Capital »

Pacific Biosciences of California shares owned by Seven Eight Capital

Quarter-by-quarter ownership of Pacific Biosciences of California (PACB) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in Pacific Biosciences of California

Tip: Access up to 7 years of quarterly data

All positions including Pacific Biosciences of California held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacific Biosciences of California by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.0M 241k 8.35
2023-06-30 $265k 20k 13.30
2023-03-31 $794k 69k 11.58
2022-09-30 $278k 48k 5.82
2022-03-31 $1.4M 157k 9.10
2021-12-31 $1.7M 84k 20.46
2020-09-30 $197k 20k 9.85

More positions owned by Seven Eight Capital

Edwards Lifesciences (EW)
Merck & Co (MRK)
Las Vegas Sands (LVS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertiv Holdings Com Cl A (VRT)
Intuitive Surgical Com New (ISRG)
ResMed (RMD)
Docusign (DOCU)
Fiserv (FI)
Xylem (XYL)
Meta Platforms Cl A (META)
Jabil Circuit (JBL)
Nextera Energy (NEE)

View all positions for Seven Eight Capital

Top funds holding Pacific Biosciences of California

ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Bank of New York Mellon
Jackson Square Partners
Bellevue Group
Point72 Asset Management
T. Rowe Price Associates
Dimensional Fund Advisors
Decheng Capital
VK Services
Lord, Abbett & Co
Charles Schwab Investment Management
Iron Triangle Partners

View all funds holding Pacific Biosciences of California